123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

Recent studies have shown that various gastrointestinal tumours express substantial amounts of vasoactive intestinal peptide (VIP) receptors. Based on these observations, we have developed a receptor scintigraphy using [123I]VIP as a radioligand. An initial series performed at our institution showed...

Descripción completa

Detalles Bibliográficos
Autores principales: Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062941/
https://www.ncbi.nlm.nih.gov/pubmed/9662242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062941/
https://www.ncbi.nlm.nih.gov/pubmed/9662242

Ejemplares similares